Together we will beat cancer

Donate

NICE doesn’t recommend ibrutinib drug for those with Waldenstrom’s macroglobulinaemia

Ibrutinib, a drug used to treat Waldenstrom’s macroglobulinaemia, is not being recommended by the National Institute for Health and Care Excellence in England

Read More

Triple negative breast cancer drug given initial ‘no’ for NHS in England

Sacituzumab govitecan (Trodelvy) is not being recommended by NICE for use in England as a treatment for some people with triple-negative breast cancer.

Read More

Aromatase inhibitors cut breast cancer recurrence in younger patients

A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women.

Read More

Immunotherapy treatment fast tracked to treat lung cancer patients in England

Hope for patients with early-stage lung cancer as new treatment approved for use on NHS England.

Read More

Atlantic rowing trio smash world record and raise thousands for cancer charities

A British woman with an incurable cancer has broken the world record for rowing across the Atlantic, raising thousands for Cancer Research UK.

Read More

Courageous children receive Star Awards in virtual celebration

Pixie Lott and other celebrity guests surprise children with messages of support in virtual Star Award ceremony, celebrates the courage of children with cancer.

Read More

Ovarian, bowel and non-Hodgkin’s lymphoma treatments approved for NHS use in Scotland

Three new treatment options made available for cancer patients in Scotland.

Read More

Targeted drug recommended to treat some advanced lung cancer patients

Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England.

Read More

Charity promotes eco-fashion with collection at Love Not Landfill pop-up

Cancer Research UK presents charity collection in collaboration with influencer Shannon Alexandra at the Love Not Landfill fashion pop-up in London.

Read More

First targeted treatment approved for advanced prostate cancer on NHS in Scotland

The targeted drug olaparib has been approved for some people with a type of advanced prostate cancer on the NHS in Scotland.

Read More